/
Other
Airway Obstruction
16
Pipeline Programs↗
4
Active Trials↗
10
Companies Involved↗
Airway obstruction is an emerging landscape with 16 programs across 10 companies. The most active players are AstraZeneca, Sanofi.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical15
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
75%
Small molecule
12 of 16 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 16 classified programs, each share of the total. Modality classified for 100% of 16 pipeline programs.
Analysis
Trial Status
21
clinical trials
Completed13 · 62%
Unknown status4 · 19%
Recruiting2 · 10%
Not yet recruiting1 · 5%
Active, not recruiting1 · 5%
Clinical Trials
Trial Activity
21 trials
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)